West Nile virus infection in individuals with pre-existing Usutu virus immunity, northern Italy, 2018.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 30 5 2019
pubmed: 30 5 2019
medline: 28 7 2020
Statut: ppublish

Résumé

In 2018, there was a large West Nile virus (WNV) outbreak in northern Italy. We observed five atypical cases of WNV infection that were characterised by the presence of WNV RNA and WNV IgG at the time of diagnosis, but no IgM response during follow-up. Neutralisation assays demonstrated pre-existing Usutu virus immunity in all patients. Besides challenging diagnosis, the immunological crosstalk between the two viruses warrants further investigation on possible cross-protection or infection enhancement effects.

Identifiants

pubmed: 31138361
doi: 10.2807/1560-7917.ES.2019.24.21.1900261
pmc: PMC6540647
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Immunoglobulin G 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2009 Aug 06;14(31):null
pubmed: 19660244
Euro Surveill. 2009 Dec 17;14(50):null
pubmed: 20070935
Euro Surveill. 2009 Dec 17;14(50):null
pubmed: 20070936
J Clin Virol. 2011 Mar;50(3):221-3
pubmed: 21156352
Euro Surveill. 2011 Aug 18;16(33):null
pubmed: 21871228
Expert Rev Vaccines. 2012 Feb;11(2):177-87
pubmed: 22309667
Clin Microbiol Infect. 2013 Oct;19(10):E451-3
pubmed: 23663225
J Infect Dis. 2013 Oct 1;208(7):1086-92
pubmed: 23821721
Euro Surveill. 2013 Sep 19;18(38):null
pubmed: 24084339
Clin Vaccine Immunol. 2014 Oct;21(10):1460-2
pubmed: 25100824
Virology. 2015 Aug;482:67-71
pubmed: 25827530
Trans R Soc Trop Med Hyg. 2015 Oct;109(10):609-18
pubmed: 26286946
Expert Rev Anti Infect Ther. 2015;13(11):1373-86
pubmed: 26325613
Clin Microbiol Infect. 2017 Jan;23(1):33-37
pubmed: 27677699
Clin Infect Dis. 2018 Apr 3;66(8):1173-1180
pubmed: 29300893
Nature. 2018 May;557(7707):719-723
pubmed: 29795354
J Med Virol. 2018 Oct;90(10):1666-1668
pubmed: 29797606
J Clin Virol. 2018 Oct;107:38-47
pubmed: 30176404

Auteurs

Alessandro Sinigaglia (A)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Monia Pacenti (M)

Microbiology and Virology Unit, Padova University Hospital, Padova, Italy.

Thomas Martello (T)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Silvana Pagni (S)

Department of Molecular Medicine, University of Padova, Padova, Italy.
Microbiology and Virology Unit, Padova University Hospital, Padova, Italy.

Elisa Franchin (E)

Department of Molecular Medicine, University of Padova, Padova, Italy.
Microbiology and Virology Unit, Padova University Hospital, Padova, Italy.

Luisa Barzon (L)

Department of Molecular Medicine, University of Padova, Padova, Italy.
Microbiology and Virology Unit, Padova University Hospital, Padova, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH